3A: PANEL: Biomaterials & Regenerative Medicine - The Solution to Enabling New Biopharma Technologies and Products?

iopharma as an industry has been rapidly growing with the development and demonstration of new engineered cell and gene therapies. However, amit is becoming increasingly recognized that many of these existing or prospective therapies could be far more efficacious, reliable, and even safe if paired with the appropriate biomaterial solutions. This panel would discuss the increasing convergence of new biopharma and the fields of cell and tissue interfacing Biomaterials - realizations, challenges, and opportunities for Biomaterials to be the key to unlocking massive biopharma potential and value.

Moderator:

Adam Jakus
BioThera3 Advising & Consulting, LLC